Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

The significance of drug interactions in the evaluation of psychotropic drugs.

1976; Wiley; Volume: 3; Issue: S1 Linguagem: Inglês

10.1111/j.1365-2125.1976.tb03709.x

ISSN

1365-2125

Autores

R A Braithwaite,

Tópico(s)

Treatment of Major Depression

Resumo

British Journal of Clinical PharmacologyVolume 3, Issue S1 p. 29-34 Free Access The significance of drug interactions in the evaluation of psychotropic drugs. RA Braithwaite, RA BraithwaiteSearch for more papers by this author RA Braithwaite, RA BraithwaiteSearch for more papers by this author First published: February 1976 https://doi.org/10.1111/j.1365-2125.1976.tb03709.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References ALEXANDERSON, B., PRICE-EVANS, D.A. & SJOQVIST, F. (1969). Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Br. Med. J., 4, 764– 768. ASBERG, M. et al. (1971). Relationship between plasma level and therapeutic effect of nortriptyline, Br. Med. J., 3, 331– 334. BRAITHWAITE, R.A. et al. (1972). Plasma concentration of amitriptyline and clinical response, Lancet i, 1297– 1300. BRAITHWAITE, R.A. & RICHENS, A. (1974). To be published. BRECKENRIDGE, A. & ORME, M. (1971). Clinical implications of enzyme induction. Ann. N.Y. Acad. Sci., 179, 421– 431. COLLABORATIVE STUDY (1974). Post. Grad. Med. J. To be published. CONNEY, A.H. (1967). Pharmacological implications of microsomal enzyme induction. Pharmac. Rev., 19, 317– 366. CURRY, S.H., D'MELLO, A. & MOULD, G.P. (1971). Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br. J. Pharmac., 42, 403– 411. GARRETTSON, L.K., PEREL, J.M. & DAYTON, P.G. (1969). Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. J. Amer. med. Assoc., 207, 2053– 2061. GRAM, L.F. & FREDRICSON-OVERO, K. (1972). Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br. Med. J., 1, 463– 465. GRANVILLE-GROSSMAN, K. (1971). In: Recent Advances in Clinical Psychiatry, p. 43. London: J. & A. Churchill. GREENWOOD, R.H., PRUNTY, F.T.G. & SILVER, J. (1973). Osteomalacia after prolonged glutethimide administration. Br. Med. J., 1, 643– 645. HAMMER, W., IDESTROM, C.M. & SJOQVIST, F. (1967). Chemical control of antidepressant drug therapy. In S. Garattini and M.N.G. Dukes (eds) Proc. 1st Int. symp. on antidepressant drugs, Milan 1966. Excerpta Medica Int. Congr. Ser., 122, 301– 310. HOLLISTER, L.E. & CURRY, S.H. (1971). Urinary excretion of chlorpromazine metabolites following single doses and in steady state conditions. Res. Comm. Chem. Path. Pharmac., 2, 330– 338. JOHNSON, D.A.W. (1973). Treatment of depression in general practice. Br. Med. J., 2, 18– 20. KRAGH-SORENSEN, P., ASBERG, M. & EGGERT-HANSEN, C. (1973). Plasma nortriptyline levels in endogenous depression. Lancet, i, 113– 115. KUPFERBERG, H.J., JEFFERY, W. & HUNNINGHAKE, D.B. (1972). Effect of methyl phenidate on plasma anticonvulsant levels. Clin. Pharmac. Ther., 13, 201– 204. McDONALD, M.G. et al. (1969). The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in man. Clin. pharmac. Ther., 10, 80– 84. MEYER, J.F., MCALLISTER, C.K. & GOLDBERG, L.I. (1970). Insidious and prolonged antagonism of guanethidine by amitriptyline. J.Amer. med. Assoc., 213, 1487– 1488. MITCHELL, J.R. et al. (1970). Guanethidine and related agents III: antagonism by drugs which inhibit the norepinephrine pump in man. J. Clin. Invest., 49, 1596– 1604. MITCHELL, J.R., ARIAS, L. & OATES, J.A. (1967). Antagonism of the antihypertensive action of guanethidine sulphate by desipramine hydrochloride. J. Am. med. Ass., 202, 973– 976. MOODY, J.P., TAIT, A. C. & TODRICK, A. (1967). Plasma levels of imipramine and desmethylimipramine during therapy. Br.J. Psychiat., 113, 183– 193. ORME, M., BRECKENRIDGE, A. & BROOKS, R.V. (1972). Interactions of benzodiazepines with warfarin. Br. Med. J., 3, 611– 614. PRESCOTT, L.F. (1971). Drug metabolism and therapeutics. Scott. med. J., 16, 121– 129. SARGANT, W. (1971). Safety of combined anti-depressant drugs. Br. med. J., 1, 555– 556. SILVERMAN, G. & BRAITHWAITE, R.A. (1973). Benzodiazepines and tricyclic antidepressant plasma levels. Br. Med. J., 3, 18– 20. SJOQVIST, F. (1965). Psychotropic drugs (2) interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc. roy. Soc. Med., 58, 967– 978. SKINNER, C., COULL, D.C. & JOHNSON, A.W. (1969). Antagonism of the hypotensive action of bethanidine and debrisoquine by tricyclic antidepressants. Lancet, ii, 564– 567. STEPHENSON, I.H. et al. (1972). Changes in human drug metabolism after long-term exposure to hypnotics. Br. Med. J., 4, 322– 324. STOCKLEY, I. (1974). In Drug Interactions, p. 15. London: The Pharmaceutical Society Press. WALTER, C.J.S. (1971). Drug plasma levels and clinical effect. Proc. roy. Soc. Med., 64, 282– 285. WILLCOX, D.R.C., GILLAN, R. & HARE, E.H. (1965). Do psychiatric outpatients take their drugs Br. Med. J., 2, 790– 792. WHARTON, R.N. et al. (1971). A potential clinical use for methylphenidate with tricyclic antidepressants. Amer. J. Psychiat. 127, 1619– 1625. Citing Literature Volume3, IssueS1February 1976Pages 29-34 ReferencesRelatedInformation

Referência(s)